Enhanced expression of caveolin-1 possesses diagnostic and prognostic value and promotes cell migration, invasion and sunitinib resistance in the clear cell renal cell carcinoma
- PMID: 28684115
- DOI: 10.1016/j.yexcr.2017.07.004
Enhanced expression of caveolin-1 possesses diagnostic and prognostic value and promotes cell migration, invasion and sunitinib resistance in the clear cell renal cell carcinoma
Erratum in
-
Corrigendum to "Enhanced expression of caveolin-1 possesses diagnostic and prognostic value and promotes cell migration, invasion and sunitinib resistance in the clear cell renal cell carcinoma" [Exp. Cell Res. (2017) 269-278].Exp Cell Res. 2018 Jan 1;362(1):244. doi: 10.1016/j.yexcr.2017.11.023. Epub 2017 Nov 22. Exp Cell Res. 2018. PMID: 29174910 No abstract available.
Abstract
Caveolin-1 (CAV1) has been identified to be up-regulated in many cancers, including clear cell renal cell carcinoma (ccRCC). However, its potential function is still unclear in ccRCC. In this study, we demonstrated that CAV1 was frequently overexpressed in renal cell carcinoma tissues and cells, and was significantly associated with various clinicopathological parameters. In addition, high CAV1 expression was associated with poor disease-free survival (DFS) rate and could serve as a useful diagnostic indicator in ccRCC patients with different clinicopathological stages. Functional experiments demonstrated that CAV1 knockdown inhibited cell migration and invasion, whereas overexpression of CAV1 promoted cell migration and invasion in ccRCC. Moreover, CAV1 expression was up-regulated in sunitinib-resistant renal cancer cell lines, and its overexpression promoted sunitinib resistance. In general, our results confirm that CAV1 plays an important role in the metastasis of kidney cancer and induces sunitinib resistance, so CAV1 function suppression may become a promising clinical treatment strategy during renal cell carcinoma metastasis and sunitinib resistance.
Keywords: CAV1; Diagnosis; Invasion; Prognosis; Sunitinib-resistance; ccRCC.
Copyright © 2017. Published by Elsevier Inc.
Similar articles
-
Mir-144-3p Promotes Cell Proliferation, Metastasis, Sunitinib Resistance in Clear Cell Renal Cell Carcinoma by Downregulating ARID1A.Cell Physiol Biochem. 2017;43(6):2420-2433. doi: 10.1159/000484395. Epub 2017 Oct 27. Cell Physiol Biochem. 2017. PMID: 29073615
-
Overexpression of placenta specific 8 is associated with malignant progression and poor prognosis of clear cell renal cell carcinoma.Int Urol Nephrol. 2017 Jul;49(7):1165-1176. doi: 10.1007/s11255-017-1578-y. Epub 2017 Mar 27. Int Urol Nephrol. 2017. PMID: 28349447
-
High-level S100A6 promotes metastasis and predicts the outcome of T1-T2 stage in clear cell renal cell carcinoma.Cell Biochem Biophys. 2015 Jan;71(1):279-90. doi: 10.1007/s12013-014-0196-x. Cell Biochem Biophys. 2015. PMID: 25120023
-
Caveolin-1, cancer and therapy resistance.Int J Cancer. 2018 Nov 1;143(9):2092-2104. doi: 10.1002/ijc.31369. Epub 2018 Mar 30. Int J Cancer. 2018. PMID: 29524224 Review.
-
Cell Intrinsic and Extrinsic Mechanisms of Caveolin-1-Enhanced Metastasis.Biomolecules. 2019 Jul 29;9(8):314. doi: 10.3390/biom9080314. Biomolecules. 2019. PMID: 31362353 Free PMC article. Review.
Cited by
-
Association of caveolin-1 protein expression with hepatocellular carcinoma: a meta-analysis and literature review.Cancer Manag Res. 2019 May 31;11:5113-5122. doi: 10.2147/CMAR.S194033. eCollection 2019. Cancer Manag Res. 2019. PMID: 31239768 Free PMC article.
-
Low DAPK1 expression correlates with poor prognosis and sunitinib resistance in clear cell renal cell carcinoma.Aging (Albany NY). 2020 Nov 16;13(2):1842-1858. doi: 10.18632/aging.103638. Epub 2020 Nov 16. Aging (Albany NY). 2020. PMID: 33201837 Free PMC article.
-
Caveolae-Associated Molecules, Tumor Stroma, and Cancer Drug Resistance: Current Findings and Future Perspectives.Cancers (Basel). 2022 Jan 25;14(3):589. doi: 10.3390/cancers14030589. Cancers (Basel). 2022. PMID: 35158857 Free PMC article. Review.
-
Review of Prognostic Expression Markers for Clear Cell Renal Cell Carcinoma.Front Oncol. 2021 Apr 28;11:643065. doi: 10.3389/fonc.2021.643065. eCollection 2021. Front Oncol. 2021. PMID: 33996558 Free PMC article. Review.
-
Enhanced YB1/EphA2 axis signaling promotes acquired resistance to sunitinib and metastatic potential in renal cell carcinoma.Oncogene. 2020 Sep;39(38):6113-6128. doi: 10.1038/s41388-020-01409-6. Epub 2020 Aug 19. Oncogene. 2020. PMID: 32814829 Free PMC article.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical